Quantum BioPharma Ltd. (QNTM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $10.35M
Last updated: Nov 17, 2026 at 11:04 AM ET
Quantum BioPharma Ltd. (QNTM) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Quantum BioPharma reported EPS of -$0.06. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
No consensus estimate is on file yet for the quarter ending Dec 31, 2026.
QNTM's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 13 quarters below that had an estimate, QNTM beat 5, missed 7 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2020, when EPS landed 895.24% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.06 | -$0.70 | -$0.70 - -$0.70 | N/A | N/A | N/A | 1 | 1 up, 0 down | Nov 12, 2026 | N/A |
| Jun 30, 2026 | -$0.47 | -$0.59 | -$0.59 - -$0.59 | +20.34% | Beat | N/A | 1 | 1 up, 0 down | Aug 13, 2026 | N/A |
| Mar 31, 2026 | -$4.17 | -$0.68 | -$0.68 - -$0.68 | -513.24% | Miss | N/A | 1 | 1 up, 0 down | May 7, 2026 | N/A |
| Sep 30, 2025 | -$1.77 | -$3.70 | -$3.70 - -$3.70 | +52.16% | Beat | N/A | 1 | 0 up, 0 down | Nov 7, 2025 | N/A |
| Jun 30, 2025 | -$3.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 6, 2025 | N/A |
| Mar 31, 2025 | -$2.33 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2025 | N/A |
| Dec 31, 2024 | -$2.70 | -$3.25 | -$3.25 - -$3.25 | N/A | N/A | N/A | 1 | 0 up, 0 down | Mar 28, 2025 | N/A |
| Sep 30, 2024 | -$4.17 | -$3.90 | -$3.90 - -$3.90 | -6.92% | Miss | N/A | 1 | 0 up, 0 down | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$5.20 | -$3.90 | N/A | -33.33% | Miss | N/A | N/A | N/A | Aug 14, 2024 | N/A |
| Mar 31, 2024 | -$3.25 | -$3.25 | N/A | 0.00% | In line | N/A | N/A | N/A | May 14, 2024 | N/A |
| Dec 31, 2023 | -$9.75 | -$9.09 | N/A | -7.25% | Miss | N/A | N/A | N/A | Mar 28, 2024 | N/A |
| Sep 30, 2023 | -$0.03 | -$0.14 | N/A | +78.57% | Beat | N/A | N/A | N/A | Nov 15, 2023 | N/A |
| Jun 30, 2023 | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 20, 2023 | N/A |
| Mar 31, 2023 | -$16.61 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 12, 2023 | N/A |
| Dec 31, 2022 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Mar 31, 2023 | N/A |
| Sep 30, 2022 | -$12.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 11, 2022 | N/A |
| Jun 30, 2022 | -$7.47 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 12, 2022 | N/A |
| Mar 31, 2022 | -$9.60 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 1, 2022 | N/A |
| Dec 31, 2021 | -$10.55 | -$68.25 | N/A | +84.54% | Beat | N/A | N/A | N/A | Mar 30, 2022 | N/A |
| Sep 30, 2021 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 15, 2021 | N/A |
| Jun 30, 2021 | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 12, 2021 | N/A |
| Mar 31, 2021 | -$24.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 20, 2021 | N/A |
| Dec 31, 2020 | -$10.55 | -$1.06 | N/A | -895.24% | Miss | N/A | N/A | N/A | Mar 17, 2021 | N/A |
| Sep 30, 2020 | -$84.50 | -$46.48 | N/A | -81.80% | Miss | N/A | N/A | N/A | Nov 12, 2020 | N/A |
| Jun 30, 2020 | -$0.50 | -$72.15 | N/A | +99.30% | Beat | N/A | N/A | N/A | Aug 7, 2020 | N/A |
| Mar 31, 2020 | -$73.79 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2020 | N/A |
| Dec 31, 2019 | -$177.45 | -$92.30 | N/A | -92.25% | Miss | N/A | N/A | N/A | Mar 2, 2020 | $159195 |
| Sep 30, 2019 | -$108.35 | N/A | N/A | N/A | N/A | -472.0% | N/A | N/A | Nov 29, 2019 | $9671 |
| Jun 30, 2019 | -$98.74 | N/A | N/A | N/A | N/A | -358.6% | N/A | N/A | Aug 28, 2019 | N/A |
| Mar 31, 2019 | -$16.28 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2019 | N/A |
| Dec 31, 2018 | -$150.29 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2018 | N/A |
| Sep 30, 2018 | $29.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2018 | $10706 |
| Jun 30, 2018 | $38.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2018 | $22332 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2024 was -$15.32, after -$26.53 the year before. It was -$82.99 for the year ended Dec 31, 2018, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2024 | -$15.32 | N/A |
| Dec 31, 2023 | -$26.53 | N/A |
| Dec 31, 2022 | -$29.20 | N/A |
| Dec 31, 2021 | -$35.07 | N/A |
| Dec 31, 2020 | -$169.34 | N/A |
| Dec 31, 2019 | -$400.81 | N/A |
| Dec 31, 2018 | -$82.99 | N/A |
Frequently Asked Questions About QNTM
How often does QNTM beat earnings estimates?
Quantum BioPharma beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -51.21%.
QNTM pages: Overview, Earnings, Competitors